• 3370 Citations
  • 26 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Helen K Chew is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Venous Thromboembolism Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Incidence Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2005

Venous Thromboembolism
Neoplasms
Incidence
Patient Discharge
Registries

Research Output 1998 2019

  • 3370 Citations
  • 26 h-Index
  • 55 Article
2 Citations (Scopus)

Preclinical development and first-in-human imaging of the integrin a v b 6 with [ 18 F]a v b 6 -binding peptide in metastatic carcinoma

Hausner, S. H., Bold, R. J., Cheuy, L. Y., Chew, H. K., Daly, M. E., Davis, R. A., Foster, C. C., Kim, E. & Sutcliffe, J., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1206-1215 10 p.

Research output: Contribution to journalArticle

Integrins
Null Lymphocytes
Carcinoma
Peptides
Neoplasm Metastasis
Breast Neoplasms
Survival
Neoplasms
Hormones
Registries
3 Citations (Scopus)

Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study

Keegan, T. H., Kushi, L. H., Li, Q., Brunson, A., Chawla, X., Chew, H. K., Malogolowkin, M. & Wun, T., Feb 9 2018, (Accepted/In press) In : Journal of Cancer Survivorship. p. 1-10 10 p.

Research output: Contribution to journalArticle

Survivors
Young Adult
Cohort Studies
Cardiovascular Diseases
Retrospective Studies
43 Citations (Scopus)

Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial

Hortobagyi, G. N., Van Poznak, C., Harker, W. G., Gradishar, W. J., Chew, H. K., Dakhil, S. R., Haley, B. B., Sauter, N., Mohanlal, R., Zheng, M. & Lipton, A., Jul 1 2017, In : JAMA oncology. 3, 7, p. 906-912 7 p.

Research output: Contribution to journalArticle

zoledronic acid
Randomized Controlled Trials
Breast Neoplasms
pamidronate
Therapeutics
36 Citations (Scopus)

Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083

Somlo, G., Frankel, P. H., Arun, B. K., Ma, C. X., Garcia, A. A., Cigler, T., Cream, L. V., Harvey, H. A., Sparano, J. A., Nanda, R., Chew, H. K., Moynihan, T. J., Vahdat, L. T., Goetz, M. P., Beumer, J. H., Hurria, A., Mortimer, J., Piekarz, R., Sand, S., Herzog, J. & 7 others, Van Tongeren, L. R., Ferry-Galow, K. V., Chen, A. P., Ruel, C., Newman, E. M., Gandara, D. R. & Weitzel, J. N., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4066-4076 11 p.

Research output: Contribution to journalArticle

Carboplatin
Proxy
Breast Neoplasms
Neoplasms
Disease-Free Survival